GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abclon Inc (XKRX:174900) » Definitions » Capital Expenditure

Abclon (XKRX:174900) Capital Expenditure : ₩-96.96 Mil (TTM As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Abclon Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Abclon's cash flow for capital expenditures for the three months ended in Jun. 2024 was ₩-34 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-96.96 Mil.


Abclon Capital Expenditure Historical Data

The historical data trend for Abclon's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abclon Capital Expenditure Chart

Abclon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10,557.23 -3,440.72 -522.89 -89.71 -49.84

Abclon Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.43 -0.99 -4.22 -57.85 -33.91

Abclon Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-96.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abclon Business Description

Traded in Other Exchanges
N/A
Address
1403, Ace Twin Tower 1, 212-1, Guro-dong, Guro-gu, Seoul, KOR, 152-779
Abclon Inc is engaged in the research and development of antibody drugs. Its business sector is divided into Antibody drug and Bio CRO.

Abclon Headlines

No Headlines